AtosUCL and Arm associate for expand the use of cloud computing in the field of life sciences
Paris, France – 1eh June 2022 -Atos and University College London (UCL) today announced that they have successfully run the Viridian virus sequencing tool, used to detect mutations in the SARS-Cov-2 strain of the coronavirus, using an Arm®-based Ampere® Altra ® processor in a native cloud environment and Atos integration expertise. This project is coordinated by the Atos Life Sciences Center of Excellence, which aims to promote a culture of exploration, discovery and co-creation to harness the power of digital technologies to advance the accuracy of medicine and accelerate discovery and processing. drug development.
As data grows rapidly and becomes more difficult to process in the life sciences, scientists rely on high-performance computing (HPC) and parallel computing to quickly process and analyze massive amounts of data.
Because the Ampere Altra platform, based on Arm Neoverse, is designed to manage workloads in the cloud, simulation and results can be obtained not only on site, but also directly in the cloud, on all types of HPC platforms and from anywhere.
The process will be much easier with Atos ’Nimbix Supercomputing Suite, which provides researchers and scientists with flexible, scalable and intuitive cloud solutions for compute-intensive workflows.
As more and more labs use Arm-based solutions, passing this proof of concept testing will allow them to run Viridian on their systems to analyze workflows. in the life sciences and detect various mutations in the SARS-CoV-2 genome, to contribute eventually in resistance to COVID-19.
This work combined the skills of a team of experts from Atos and Arm focused on hardware and software optimizations, as well as a team of scientists from UCL focused on scientific applications for particular case of this use. The collaboration has optimized both software and hardware in this co-design effort to meet cutting-edge genomics research workflow requirements, which are already deployed in clinical settings.
Emmanuel Le Roux, SVP, HPC, AI and Quantum Director at Atos said: “Being the undisputed European leader in HPC not only means being the largest supplier of the system to European HPC centers in terms of PetaFlops, but also ng collaborates closely with many scientific and research institutions in Europe to enable a variety of day-to-day vital data production and simulation. This work, under the leadership of Atos Life Sciences Center of Excellenceshow that collaboration between academia and industry industrial, thanks to the power of supercomputing, opens up new avenues for scientific advancement. Now we again show the importance calculation hybrid to stimulate innovation and provide scientists with real-world applications for life sciences. »
Alex Wade, Associate Researcher, UCL : “This co-design effort between Arm, Atos and UCL has optimized both Arm’s new hardware and its cutting-edge genomics software, further enhancing their real-world life science potential. applications. The collaboration with industry partners has resulted in an important concept for the future of HPC applications, where hardware and software are willing to work together, as opposed to the standard view of constantly updating software to match those. new version of hardware equipment. This work was carried out within the framework of the Center of Excellence in Computational Biomedicine (CompBioMed) and became possible due to CompBioMed’s extensive interdisciplinary expertise. Arm and Atos have been important partners in this work. We hope that our project will lead to future collaborations and will serve as a model for other designing activities. »
Atos is an international leader in digital transformation with 111,000 employees and annual revenues of approximately € 11 billion. European number one in cloud, cybersecurity and supercomputers, the Group provides integrated solutions for all sectors, in 71 countries. A pioneer in decarbonization services and products, Atos is committed to providing secure and decarbonized digital solutions to its customers. Atos is an SE (European Company) listed on Euronext Paris and part of the CAC 40 ESG and Next 20 indices.
Atos ’raison d’être helped shape the information space. Using its skills and services, the Group supports the development of knowledge, education and research in a multicultural approach and contributes to the development of scientific and technological excellence. Worldwide, Atos enables its customers and employees, and more generally the most people, to live, work and thrive resiliently and with complete confidence in the information space.
Constance Arnoux | firstname.lastname@example.org | +33 (0) 6 44 12 16 35
PR-Atos, UCL and Arm join forces to expand the use of cloud computing in the field of life sciences